Dong L. Chen
Zhongshan 2nd Road
Guangzhou, 510080, China
Guangzhou, 510080, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Anti-PD-L1 blockade facilitates antitumor effects of radiofrequency ablation by improving tumor immune microenvironment in hepatocellular carcinoma.
Journal: Apoptosis : an international journal on programmed cell death
Published: September 13, 2024
Laparoscopic liver resection versus radiofrequency ablation for hepatocellular carcinoma within Milan criteria: a meta-analysis and systematic review.
Journal: Frontiers in oncology
Published: June 02, 2024
Fatty acid metabolism affects hepatocellular carcinoma progression via the PPAR-γ signaling pathway and fatty acid β-oxidation.
Journal: International immunopharmacology
Published: April 20, 2024
CircMYBL2 facilitates hepatocellular carcinoma progression by regulating E2F1 expression.
Journal: Oncology research
Published: November 08, 2023
Complete response of recurrent perihilar cholangiocarcinoma following sintilimab combined with lenvatinib plus S-1: a case report and review of literature.
Journal: Anti-cancer drugs
Published: May 25, 2023
MCM6 promotes intrahepatic cholangiocarcinoma progression by upregulating E2F1 and enhancing epithelial-mesenchymal transition.
Journal: Carcinogenesis
Published: October 24, 2022
Hypoxic Hepatocellular Carcinoma Cells Acquire Arsenic Trioxide Resistance by Upregulating HIF-1α Expression.
Journal: Digestive diseases and sciences
Published: January 13, 2021
Myofibroblast-Specific Msi2 Knockout Inhibits HCC Progression in a Mouse Model.
Journal: Hepatology (Baltimore, Md.)
Published: September 09, 2020
Clinical management of vascular lake during transarterial chemoembolization with CalliSpheres drug-eluting beads (DEBs) for the treatment of hepatocellular carcinoma.
Journal: Translational cancer research
Published: January 31, 2020
Last Updated: 09/26/2026